Q2 2024 · 13F-HR
SECTOR GAMMA ASholdings as filed
Filed 2024-08-09 · accession 0000945621-24-000640
$267.7M
Reported value
28
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 375558103 | GILD | GILEAD SCIENCES INC | $28.8M | 10.8% | 420,163 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $25.0M | 9.36% | 895,000 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $22.2M | 8.30% | 535,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $20.8M | 7.79% | 264,890 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $13.2M | 4.91% | 24,279 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $13.0M | 4.85% | 220,000 | Common | SOLE |
| 45337C102 | INCY | INCYTE CORP | $12.3M | 4.61% | 203,376 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $10.5M | 3.93% | 107,098 | Common | SOLE |
| 09062X103 | BIIB | BIOGEN INC | $10.2M | 3.81% | 43,985 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $9.4M | 3.50% | 30,000 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $9.2M | 3.45% | 85,000 | Common | SOLE |
| 071813109 | BAX | BAXTER INTL INC | $8.7M | 3.25% | 260,000 | Common | SOLE |
| 36266G107 | GEHC | GE HEALTHCARE TECHNOLOGIES I | $8.1M | 3.03% | 104,000 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $8.1M | 3.03% | 170,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $7.4M | 2.75% | 115,472 | Common | SOLE |
| 002824100 | ABT | ABBOTT LABS | $7.3M | 2.72% | 70,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $7.0M | 2.63% | 52,861 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $6.5M | 2.42% | 35,000 | Common | SOLE |
| 28176E108 | EW | EDWARDS LIFESCIENCES CORP | $6.4M | 2.39% | 69,153 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $5.3M | 1.96% | 121,844 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $5.2M | 1.95% | 63,348 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $4.7M | 1.75% | 194,000 | Common | SOLE |
| 090572207 | BIO | BIO RAD LABS INC | $4.6M | 1.72% | 16,829 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $3.7M | 1.38% | 15,240 | Common | SOLE |
| N72482149 | — | QIAGEN NV | $3.4M | 1.28% | 83,484 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $3.0M | 1.11% | 45,000 | Common | SOLE |
| 516544103 | LNTH | LANTHEUS HLDGS INC | $2.5M | 0.95% | 31,712 | Common | SOLE |
| 92556V106 | VTRS | VIATRIS INC | $1.1M | 0.41% | 103,106 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.